Caxton Associates (UK)’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-316,136
Closed -$1.46M – 894
2026
Q1
$1.46M Sell
316,136
-302,172
-49% -$1.58M 0.03% 288
2025
Q4
$3.09M Sell
618,308
-124,418
-17% -$648K 0.06% 117
2025
Q3
$3.77M Buy
742,726
+124,900
+20% +$550K 0.09% 96
2025
Q2
$2.66M Buy
617,826
+330,946
+115% +$1.64M 0.07% 142
2025
Q1
$1.73M Buy
+286,880
New +$1.45M 0.06% 188

Other funds holding MPT

Caxton Associates (UK)'s MPT Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Medical Properties Trust (MPT) in Q2 2026, closing a stake of 316,136 shares — an estimated $1.46M sold.

Caxton Associates (UK) first reported a position in MPT in Q1 2025 and held it in 5 quarters. The position peaked at $3.77M in Q3 2025. 490 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Medical Properties Trust position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 316,136 Medical Properties Trust shares in Q2 2026, an estimated $1.46M.
  • Caxton Associates (UK) first reported a position in Medical Properties Trust in Q1 2025 and held it in 5 quarters.
  • Caxton Associates (UK)'s Medical Properties Trust position peaked at $3.77M in Q3 2025.
  • 490 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.